Navigation Links
Australia to Show Leniency towards U.S. Pharmaceutical Companies

Australian would remove the amendment which states to reduce the price of the drug obtained from US.

The Trade Minister and the // acting Prime Minister Mark Vaile reported that this amendment was accepted because it was supported by the major opposition party in Australia (Labor Party).

The reason that the party supported the amendment was to prevent the delay in the introduction of new generic drugs.

According to the amendment the Australian authorities have the power to levy heavy fines and ask the pharmaceutical company to reimburse for the lost sales.

Apart from that the company has to pay extra cash to the federal and state government. This amendment became a law and was in function from the first of January 2005.

But the Australian government also considers the risks the pharmaceutical company has to face and has told that this act would be reviewed.

The government told the companies that the act would be removed if the companies proved that the act has been misused by the Australian government.

But still the Australian government still wishes that both the parties discuss on this issue and come out with a better law which would not be detrimental to both the Australian government and the pharmaceutical companies.

He also mentioned that the pharmaceutical companies can delay their patents only if there is an enhancement in the profits due to the drug.

But the government will never allow the misuse of the law at any cost.


'"/>




Page: 1

Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australia earmarks $74 Million to Fight Bird Flu
3. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
4. Obesity among The Poor in Australia.
5. Increase In Health Insurance Premium Likely In Australia
6. Australian Company Gets $10 million For Developing Skin Cancer Gel
7. Australian Health funds stand accused
8. Bird flu scare in Australia
9. Australia awaits US FDA reports on ADHD drugs
10. No booster vaccine For every fourth child in Australia
11. Australia Witnesses A Fall In the Number of Organ Donors
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...is the inability of a man to achieve or maintain a...needs of his partner. Most men experience this at ...d are not psychologically affected by it. Some men...ED (impotence), and often leads to diminished self...
... may be worse for women in childbearing age than p...The Journal of Maxillofacial Surgery says//. The ...the wisdom tooth may be an indicator of premature ...amined 1,020 women in the childbearing age group f...
... million HIV positive people and we are ranked the... positive people next to South Africa//. UN Secre...ia and the Pacific Nafis sadik said that the steps... HIV/AIDS is in good progress but more has to be d...
... has been set up in Pakistani Kashmir to provide s...astating earthquake. The hospital was erected in j... German doctors and other paramedical staff. The m...to Muzaffarabad, the Kashmir capital, in four heli...
Other Medicine News:Health News:Erectile dysfunction: an early warning sign of clinically silent coronary artery disease? 2Health News:More collaborations and strengthening of India’s AIDS control body require 2
(Date:9/4/2008)...o Enroll 750 Women at More Than 100 Sites in the U...atRx Pharmaceuticals, a,privately-held biopharmace...alization of compounds to treat endocrine, metabol...hat it has initiated a second,Phase 3 clinical tri...,s,estrogen-free oral therapy in development for t...
(Date:9/4/2008)...Remain on Schedule with Two Abstracts Accepted for... in November 2008, BRIDGEWATER, N.J., Sept. 4 /PR...cialty pharmaceutical company focused on the treat...y announced the appointment of,Peter L. Garrambone... Garrambone,s career includes more than 50 pharmac...
(Date:9/3/2008)... up results from chronically infected Hepatitis C,... obtained earlier in 2008, - Study is the first ... antiviral effect of therapeutic Hepatitis C...upport move into a second generation, vaccine for...hrough TLR activatio...
(Date:9/3/2008)...ny to Discuss Phase 3 Plans with FDA, PRINCETON, ...Inc.,announced today that it successfully complet...he company,s new, innovative low-dose, once-weekly... by its internal product,code AG-200-15. The Phase...,primary endpoint of ovulation suppression, cycle ...
Breaking Medicine Technology:QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4VIDEO from Medialink and The Childrens Hospital of Philadelphia 3A New Research Rules of the Road for Teens and Passengers 13354 1VIDEO from Medialink and The Childrens Hospital of Philadelphia 3A New Research Rules of the Road for Teens and Passengers 13354 2San Diego Harbor Police Deploy BIO key 28R 29 Automated Vehicle Location System 2391 1San Diego Harbor Police Deploy BIO key 28R 29 Automated Vehicle Location System 2391 2San Diego Harbor Police Deploy BIO key 28R 29 Automated Vehicle Location System 2391 3Scientists uncover a novel mechanism that regulates carbon dioxide fixation in plants 2389 1Scientists uncover a novel mechanism that regulates carbon dioxide fixation in plants 2389 2Surface dislocation nucleation 3A Strength is but skin deep at the nanoscale Penn engineers discover 3677 1Surface dislocation nucleation 3A Strength is but skin deep at the nanoscale Penn engineers discover 3677 2
...After Sleep Onset and Total Sleep,Time, and Key Se...,Sleep, Were Met at Both Doses, HAMBURG, Germany a...tCall/ -- Evotec AG announced today positive,top-l... of EVT 201,in patients with chronic primary insom...lator (pPAM) of the GABAA receptor complex.,The do...
... 2007 - Genentech, Inc. (NYSE:DNA),today announced...e,III clinical trials studying Herceptin(R) (trast...e breast cancer. Data presented,at the 43rd Annual...ogy (ASCO) showed that, with median follow-up of n...andard adjuvant therapy,significantly improved ove...
Other Medicine Technology:Evotec Reports Positive Proof-of-Concept Top-Line Results with,Insomnia Drug Candidate EVT 201 2Evotec Reports Positive Proof-of-Concept Top-Line Results with,Insomnia Drug Candidate EVT 201 3Evotec Reports Positive Proof-of-Concept Top-Line Results with,Insomnia Drug Candidate EVT 201 4Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 2Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 3Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 4Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 5Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 6
...Motor Module, with hand throttle. Accepts all 1000...10ft. air hose 9000-000, or existing hose with Mic...000, or existing hose with Linvatec/Hall connector... hose with 3M connector (1000-300). , 10ft air hos...
Pneumatic micro reciprocating saw, 15k cpm, available with various hose connector styles.
Pneumatic impactor, general surgery, available in various hose connector styles.
The SmartDriver System consists of a pistol-grip handpiece available in Pneumatic, Electric and Battery Power, with a wide range of couplers that can be used in a variety of orthopedic surgical appli
Medicine Products: